- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
COVID-19
The Rheumatology Network COVID-19 clinical focus page provides information on the latest COVID-19 news, study and clinical trial findings, and clinical guideline updates for the treatment of COVID-19. We feature expert interviews with leading physicians and investigators, articles, videos, podcasts, and breaking FDA approvals for COVID-19 drugs.
Ruxolitinib Treatment did not Benefit Patients With COVID-19
April 29, 2022
investigators initially theorized the drug may positively impact patients with COVID-19 treated with ruxolitinib.
Gout Increases Risk of COVID-19-Related Death in Women
April 13, 2022
“Understanding the drivers of this increased risk in women with gout warrants further investigation in larger datasets," investigators stated.
Rheumatoid Arthritis Quiz: Effectiveness of COVID-19 Vaccines in Patients With RA
April 11, 2022
At the outset of the COVID-19 pandemic, there were concerns that patients with rheumatoid arthritis would be more vulnerable due to their condition and its treatment. What impact has the availability of vaccines against COVID-19 had on the vulnerability of patients with rheumatoid arthritis? Test your knowledge with this quiz.
Certain DMARDs Reduce Vaccine Efficacy in Patients With RA
April 07, 2022
“These data suggest that vaccine responses are reduced but can be improved by sufficient vaccine/virus exposure,” investigators stated.
COVID-19 Linked to More Severe Lung Outcomes in Patients With Rheumatic Disease
March 28, 2022
Patients with rheumatic disease were more likely to have a Pulmonary X-Ray Severity score >9, were more likely to require mechanical ventilation, and had a higher risk of death when compared with controls.
Worse COVID-19 Outcomes Seen in Patients With Systemic Sclerosis
March 23, 2022
A retrospective study analyzed patients with systemic sclerosis to determine prevalence, severity, and mortality within this patient population.
Telemedicine Reviews Varied Among Patients With Psoriatic Arthritis
February 28, 2022
“This dramatic change in healthcare delivery led to significant challenges amongst healthcare management teams, healthcare professionals as well as patients, especially during the early phases of implementation," investigators stated.
Temporary Methotrexate Withdrawal Improves COVID-19 Immunogenicity
February 25, 2022
Results indicated that a brief methotrexate withdrawal after COVID-19 vaccine doses may improve immunogenicity in patients with rheumatoid arthritis.
American College of Rheumatology Revises COVID-19 Vaccine Clinical Guidance, Supports 4th Dose
February 04, 2022
The American College of Rheumatology (ACR) has published guidance regarding COVID-19 vaccination for patients with rheumatic diseases, with emphasis placed on supplemental and booster doses for patients with rheumatic disease.
Xavier Mariette, MD, PhD: Antibody Response in Rituximab-Treated Patients After COVID-19 Vaccination
February 03, 2022
Xavier Mariette, MD, PhD, explains the results of his study examining how rituximab impacts B-cell and T-cell response to COVID-19 vaccine in patients with rheumatic disease.